Cynata Therapeutics Limited

ASX:CYP Stok Raporu

Piyasa değeri: AU$42.5m

Cynata Therapeutics Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Cynata Therapeutics is forecast to grow earnings and revenue by 34.1% and 70.4% per annum respectively while EPS is expected to grow by 54.2% per annum.

Anahtar bilgiler

34.1%

Kazanç büyüme oranı

54.2%

EPS büyüme oranı

Biotechs kazanç büyümesi15.2%
Gelir büyüme oranı70.4%
Gelecekteki özkaynak getirisin/a
Analist kapsamı

Low

Son güncelleme05 Aug 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Here's Why We're Watching Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

Sep 21
Here's Why We're Watching Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

Will Cynata Therapeutics (ASX:CYP) Spend Its Cash Wisely?

May 29
Will Cynata Therapeutics (ASX:CYP) Spend Its Cash Wisely?

We're A Little Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn Rate

Feb 09
We're A Little Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn Rate

We're Interested To See How Cynata Therapeutics (ASX:CYP) Uses Its Cash Hoard To Grow

Feb 02
We're Interested To See How Cynata Therapeutics (ASX:CYP) Uses Its Cash Hoard To Grow

We Think Cynata Therapeutics (ASX:CYP) Can Easily Afford To Drive Business Growth

Sep 09
We Think Cynata Therapeutics (ASX:CYP) Can Easily Afford To Drive Business Growth

Here's Why We're Not At All Concerned With Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

May 26
Here's Why We're Not At All Concerned With Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

Here's Why We're Not Too Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

Dec 31
Here's Why We're Not Too Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn Situation

We're Not Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn

Aug 11
We're Not Worried About Cynata Therapeutics' (ASX:CYP) Cash Burn

Kazanç ve Gelir Büyüme Tahminleri

ASX:CYP - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (AUD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
6/30/20267-5-4-41
6/30/20251-8-8-81
6/30/20242-10-10-10N/A
3/31/20242-12-11-11N/A
12/31/20232-14-12-12N/A
9/30/20232-14-13-13N/A
6/30/20232-14-14-14N/A
3/31/20232-12-12-12N/A
12/31/20223-9-10-10N/A
9/30/20225-7-7-7N/A
6/30/20228-5-3-3N/A
3/31/20228-5-2-2N/A
12/31/20218-4-1-1N/A
9/30/20215-6-3-3N/A
6/30/20212-8-5-5N/A
3/31/20212-7-5-5N/A
12/31/20203-6-5-5N/A
9/30/20205-5-4-4N/A
6/30/20207-4-3-3N/A
3/31/20206-6-5-5N/A
12/31/20194-8-7-7N/A
9/30/20193-8-7-7N/A
6/30/20191-8-7-7N/A
3/31/20191-7-6-6N/A
12/31/20181-6-5-5N/A
9/30/20181-5-4-4N/A
6/30/20181-5-4-4N/A
3/31/20181-5N/A-4N/A
12/31/20171-5N/A-5N/A
9/30/20172-5N/A-4N/A
6/30/20172-5N/A-4N/A
3/31/20172-4N/A-3N/A
12/31/20162-3N/A-2N/A
9/30/20161-4N/A-3N/A
6/30/20161-5N/A-4N/A
3/31/20161-5N/A-4N/A
12/31/20151-5N/A-4N/A
9/30/20151-4N/A-4N/A
6/30/20150-4N/A-3N/A
3/31/20150-3N/A-2N/A
12/31/20140-3N/A-2N/A
9/30/20140-3N/A-2N/A
6/30/20140-3N/A-2N/A
3/31/20140-3N/A-1N/A
12/31/20130-2N/A-1N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: CYP is forecast to remain unprofitable over the next 3 years.

Kazançlar ve Piyasa: CYP is forecast to remain unprofitable over the next 3 years.

Yüksek Büyüme Kazançları: CYP is forecast to remain unprofitable over the next 3 years.

Gelir ve Pazar: CYP's revenue (70.4% per year) is forecast to grow faster than the Australian market (5.7% per year).

Yüksek Büyüme Geliri: CYP's revenue (70.4% per year) is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if CYP's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin